Safety profile of dalfampridine extended release in multiple sclerosis: 5-year postmarketing experience in the United States

por Jara, Michele, Aquilina, Thomas, Aupperle, Peter, Rabinowicz, Adrian L
Publicado 2015

Treatment patterns and health care resource utilization associated with dalfampridine extended release in multiple sclerosis: a retrospective claims database analysis

por Guo, Amy, Grabner, Michael, Palli, Swetha Rao, Elder, Jessica, Sidovar, Matthew, Aupperle, Peter, Krieger, Stephen
Publicado 2016